Medgold Resources reports on the status of the previously announced proposed sale of the Company's Tlamino Project to MetalsTech. MetalsTech has advised the Company that it will not be exercising its option to acquire the Project. As a result, the agreement between the parties has terminated. Management of the Company is reviewing a number of [...]
Medgold Resources Corp. is pleased to announce that it has entered into a binding option agreement with MetalsTech Ltd. , in regard to the sale of the Company's interest in the Tlamino Project in Serbia. Under the terms of the Agreement, Medgold has granted MetalsTech an exclusive option to acquire a 100% interest in the Tlamino Project for a total [...]
Medgold Resources Corp. | announces that Mr. Simon Ridgway has resigned as Executive Chairman and as a Director of Medgold in order to pursue other business interests. Mr. Ridgway is recognized and warmly thanked for his foundational role in the establishment of Medgold, and for his strategic leadership of the Company through its acquisition [...]
Medgold Resources Corp. | is pleased to announce the completion of a positive Preliminary Economic Assessment for the Barje gold deposit at its Tlamino Project, Serbia . The highlights of the PEA are as follows: - Based on simple open-pit mining methods and the production of a flotation concentrate via conventional processing techniques, the [...]
Medgold Corp. is pleased to announce that it has entered into a definitive Option Agreement with Fortuna Silver Mines Inc. to acquire Fortuna’s 51% interest in the Tlamino Project, located in Serbia. The terms of the Agreement provide Medgold with an exclusive option to purchase Fortuna’s 51% interest in the Project for a cash consideration of US [...]
Medgold Resources Corp. is pleased to announce the completion of metallurgical test work from the Barje Prospect, within the Tlamino Project in southern Serbia. Highlights of this work are as follows: - Conventional flotation has produced a concentrate grading 48.9 g/t Au and 824 g/t Ag with recoveries to concentrate of 83.4 % for gold and 82.4 [...]
Medgold Resources Corp. is pleased to announce the initiation of a Preliminary Economic Assessment in respect to the Barje Prospect within the Tlamino Project in southern Serbia. The purpose of this study will be to constrain the self-standing economics of the Project, and most particularly its capacity to yield a marketable metal concentrate, to [...]
Medgold Resources Corp. is pleased to report that it has closed its previously announced private placement financing with the issuance of 40 million units at $0.05 per unit, for gross proceeds of $2 million, which included the sale of $850,000 worth of Units to a group of strategic investors led by Palisades Goldcorp Ltd. Each unit consists of one [...]
Medgold Resources Corp. announces that it proposes, subject to stock exchange approval, to complete a non-brokered private placement financing of up to 40 million units at $0.05 per unit, for proceeds of up to $2 million. Each unit will consist of one common share and one full warrant, each warrant entitling the holder to purchase one additional [...]
Medgold Resources Corp. | is pleased to announce that it has entered into a non-binding Letter of Intent with Fortuna Silver Mines Inc. to acquire Fortuna's 51% interest in the Tlamino Project located in Serbia . Under the terms of the Letter, Medgold has secured an exclusive option to purchase Fortuna's 51% interest in the Project for a cash [...]
Medgold Resources Corp. | announces that further to its news release of April 28, 2020, the Company is continuing to rely on the extension provided by the securities regulators as a result of the COVID-19 pandemic regarding the deadline for filing and delivering its audited financial statements and MD&A for the fiscal year ended December 31, 2019 [...]
Medgold Resources Corp. | announces that it is relying on the extension provided by the securities regulators as a result of the COVID-19 pandemic regarding the deadline for filing and delivering its audited financial statements and MD&A for the fiscal year ended December 31, 2019. Accordingly, the Company will file such financials no later than [...]